FemCure 23S rRNA gene Chlamydia trachomatis
Direct assessment of 23S rRNA gene resistance associated mutations (RAMs) in Chlamydia trachomatis positive samples in women from before treatment up to one month post treatment; FemCure study population, The Netherlands.